Delivering the Next Generation of Biotherapies: Execution Realities and Smart Packaging Trade-offs

As advanced biotherapies, RNA-based treatments, and personalized medicines expand, traditional high-volume packaging lines are being forced to adapt. Legacy systems built for standardized production lines fail when confronted with small-batch, high-value, and temperature-sensitive biological modalities. This panel bridges the gap between upstream biological complexity and downstream packaging execution.Industry experts will discuss the practical constraints they navigate when adapting packaging to these sensitive therapies. The conversation will focus on the real-world trade-offs between manufacturing flexibility and speed, the realities of low-volume packaging operations, and how packaging formats must evolve to maintain product stability without over-complicating commercial scale-up.